US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist

10.965
-2.485-18.48%

Close May 10 16:00 ET

11.070
+0.105+0.96%

Post 19:59 ET

3.07BMarket Cap-6058P/E (TTM)

Iovance Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-22.51%-122.28M

-23.59%-361.82M

-8.11%-83.97M

-32.10%-84.08M

-21.02%-93.95M

-35.25%-99.82M

-28.44%-292.76M

-44.24%-77.67M

-10.32%-63.65M

-43.75%-77.64M

Net income from continuing operations

-5.22%-112.98M

-12.16%-444.04M

-10.50%-116.38M

-14.20%-113.76M

-7.23%-106.53M

-17.21%-107.37M

-15.67%-395.89M

-6.03%-105.32M

-15.67%-99.62M

-22.12%-99.35M

Operating gains losses

---96K

--70K

---106K

--357K

----

Depreciation and amortization

73.90%9.91M

56.74%33.13M

70.21%9.71M

89.83%9.88M

49.41%7.84M

14.44%5.7M

51.18%21.14M

27.84%5.71M

31.20%5.2M

88.98%5.25M

Deferred tax

---1.41M

---3.48M

---1.76M

---1.24M

---477K

--0

----

Change In working capital

-153.71%-32.55M

-125.48%-6.52M

295.87%11.89M

-45.73%5.89M

-77.66%-11.47M

-24.64%-12.83M

-111.78%-2.89M

-85.75%3M

182.44%10.85M

-177.26%-6.46M

-Change in receivables

---83K

---149K

----

---33K

--0

----

-Change in inventory

---6.74M

---10.12M

---923K

--354K

---9.55M

--0

----

-Change in prepaid assets

239.16%5.89M

-372.39%-10.06M

-280.89%-5.15M

192.92%2.15M

-368.88%-2.83M

-13.89%-4.23M

-176.76%-2.13M

26.04%2.85M

-165.12%-2.32M

2.43%1.05M

-Change in payables and accrued expense

-378.19%-28.83M

1,984.92%24.6M

744.95%20.83M

-55.02%6.17M

147.11%3.64M

17.05%-6.03M

-95.73%1.18M

-87.24%2.47M

391.75%13.71M

-187.32%-7.72M

-Change in other current liabilities

-8.56%-2.79M

-455.82%-10.79M

-17.85%-2.72M

-424.81%-2.81M

-1,369.81%-2.69M

-472.32%-2.57M

66.98%-1.94M

-368.15%-2.31M

78.55%-536K

113.98%212K

Cash from discontinued investing activities

Operating cash flow

-22.51%-122.28M

-23.59%-361.82M

-8.11%-83.97M

-32.10%-84.08M

-21.02%-93.95M

-35.25%-99.82M

-28.44%-292.76M

-44.24%-77.67M

-10.32%-63.65M

-43.75%-77.64M

Investing cash flow

Cash flow from continuing investing activities

-172.69%-111.51M

-160.53%-155.24M

-15,901.52%-72.85M

-207.19%-79.01M

-263.72%-156.78M

77.30%153.4M

194,184.09%256.46M

-99.34%461K

478.25%73.72M

160.17%95.76M

Net PPE purchase and sale

26.36%-4.17M

-9.13%-22.29M

-16.78%-3.53M

-157.89%-3.58M

-108.04%-9.52M

50.49%-5.66M

45.64%-20.43M

60.07%-3.02M

85.68%-1.39M

52.41%-4.58M

Net business purchase and sale

---52.57M

---212.63M

--253K

---3.38M

---209.51M

--0

----

Net investment purchase and sale

-134.43%-54.76M

-71.22%79.68M

-2,097.39%-69.57M

-195.95%-72.06M

-37.96%62.25M

62.38%159.06M

634.31%276.88M

-95.47%3.48M

234.78%75.1M

167.09%100.34M

Cash from discontinued investing activities

Investing cash flow

-172.69%-111.51M

-160.53%-155.24M

-15,901.52%-72.85M

-207.19%-79.01M

-263.72%-156.78M

77.30%153.4M

194,184.09%256.46M

-99.34%461K

478.25%73.72M

160.17%95.76M

Financing cash flow

Cash flow from continuing financing activities

-25.02%193.58M

143.47%462.96M

-99.50%962K

90,033.33%202.8M

149.59%1.03M

18,119.62%258.17M

-20.53%190.15M

4,492.17%190.58M

-98.92%225K

-101.26%-2.07M

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

-23.91%197.91M

144.47%463.28M

-100.00%1K

--203.18M

--0

--260.1M

-6.72%189.5M

--189.5M

--0

Proceeds from stock option exercised by employees

--364K

-24.99%2.47M

6.90%1.15M

--0

127.84%1.33M

--0

-90.61%3.3M

-74.14%1.07M

-98.92%225K

-84.32%582K

Net other financing activities

-143.70%-4.7M

-5.51%-2.8M

---186K

---379K

---301K

---1.93M

---2.65M

--0

----

Cash from discontinued financing activities

Financing cash flow

-25.02%193.58M

143.47%462.96M

-99.50%962K

90,033.33%202.8M

149.59%1.03M

18,119.62%258.17M

-20.53%190.15M

4,492.17%190.58M

-98.92%225K

-101.26%-2.07M

Net cash flow

Beginning cash position

-23.87%181.32M

182.47%238.16M

167.76%334.15M

158.89%296.44M

458.61%549.91M

182.47%238.16M

15.73%84.31M

92.96%124.8M

28.88%114.51M

-28.68%98.44M

Current changes in cash

-112.90%-40.21M

-135.17%-54.1M

-237.48%-155.85M

285.80%39.7M

-1,654.74%-249.71M

2,106.16%311.75M

1,242.60%153.85M

477.24%113.37M

142.57%10.29M

132.65%16.06M

Effect of exchange rate changes

---491K

---2.74M

--3.02M

---1.99M

---3.77M

--0

----

--0

----

End cash Position

-74.43%140.62M

-23.87%181.32M

167.76%334.15M

158.89%296.44M

458.61%549.91M

182.47%238.16M

92.96%124.8M

28.88%114.51M

Free cash flow

-19.88%-126.45M

-22.65%-384.11M

-8.43%-87.5M

-34.79%-87.66M

-25.86%-103.47M

-23.74%-105.48M

-17.95%-313.18M

-31.39%-80.69M

3.48%-65.04M

-29.21%-82.21M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-22.51%-122.28M	-23.59%-361.82M	-8.11%-83.97M	-32.10%-84.08M	-21.02%-93.95M	-35.25%-99.82M	-28.44%-292.76M	-44.24%-77.67M	-10.32%-63.65M	-43.75%-77.64M
Net income from continuing operations	-5.22%-112.98M	-12.16%-444.04M	-10.50%-116.38M	-14.20%-113.76M	-7.23%-106.53M	-17.21%-107.37M	-15.67%-395.89M	-6.03%-105.32M	-15.67%-99.62M	-22.12%-99.35M
Operating gains losses	---96K	--70K	---106K	--357K	----	----	----	----	----	----
Depreciation and amortization	73.90%9.91M	56.74%33.13M	70.21%9.71M	89.83%9.88M	49.41%7.84M	14.44%5.7M	51.18%21.14M	27.84%5.71M	31.20%5.2M	88.98%5.25M
Deferred tax	---1.41M	---3.48M	---1.76M	---1.24M	---477K	--0	--0	--0	--0	----
Change In working capital	-153.71%-32.55M	-125.48%-6.52M	295.87%11.89M	-45.73%5.89M	-77.66%-11.47M	-24.64%-12.83M	-111.78%-2.89M	-85.75%3M	182.44%10.85M	-177.26%-6.46M
-Change in receivables	---83K	---149K	----	----	---33K	--0	--0	----	----	----
-Change in inventory	---6.74M	---10.12M	---923K	--354K	---9.55M	--0	--0	--0	--0	----
-Change in prepaid assets	239.16%5.89M	-372.39%-10.06M	-280.89%-5.15M	192.92%2.15M	-368.88%-2.83M	-13.89%-4.23M	-176.76%-2.13M	26.04%2.85M	-165.12%-2.32M	2.43%1.05M
-Change in payables and accrued expense	-378.19%-28.83M	1,984.92%24.6M	744.95%20.83M	-55.02%6.17M	147.11%3.64M	17.05%-6.03M	-95.73%1.18M	-87.24%2.47M	391.75%13.71M	-187.32%-7.72M
-Change in other current liabilities	-8.56%-2.79M	-455.82%-10.79M	-17.85%-2.72M	-424.81%-2.81M	-1,369.81%-2.69M	-472.32%-2.57M	66.98%-1.94M	-368.15%-2.31M	78.55%-536K	113.98%212K
Cash from discontinued investing activities
Operating cash flow	-22.51%-122.28M	-23.59%-361.82M	-8.11%-83.97M	-32.10%-84.08M	-21.02%-93.95M	-35.25%-99.82M	-28.44%-292.76M	-44.24%-77.67M	-10.32%-63.65M	-43.75%-77.64M
Investing cash flow
Cash flow from continuing investing activities	-172.69%-111.51M	-160.53%-155.24M	-15,901.52%-72.85M	-207.19%-79.01M	-263.72%-156.78M	77.30%153.4M	194,184.09%256.46M	-99.34%461K	478.25%73.72M	160.17%95.76M
Net PPE purchase and sale	26.36%-4.17M	-9.13%-22.29M	-16.78%-3.53M	-157.89%-3.58M	-108.04%-9.52M	50.49%-5.66M	45.64%-20.43M	60.07%-3.02M	85.68%-1.39M	52.41%-4.58M
Net business purchase and sale	---52.57M	---212.63M	--253K	---3.38M	---209.51M	--0	--0	--0	--0	----
Net investment purchase and sale	-134.43%-54.76M	-71.22%79.68M	-2,097.39%-69.57M	-195.95%-72.06M	-37.96%62.25M	62.38%159.06M	634.31%276.88M	-95.47%3.48M	234.78%75.1M	167.09%100.34M
Cash from discontinued investing activities
Investing cash flow	-172.69%-111.51M	-160.53%-155.24M	-15,901.52%-72.85M	-207.19%-79.01M	-263.72%-156.78M	77.30%153.4M	194,184.09%256.46M	-99.34%461K	478.25%73.72M	160.17%95.76M
Financing cash flow
Cash flow from continuing financing activities	-25.02%193.58M	143.47%462.96M	-99.50%962K	90,033.33%202.8M	149.59%1.03M	18,119.62%258.17M	-20.53%190.15M	4,492.17%190.58M	-98.92%225K	-101.26%-2.07M
Net issuance payments of debt	----	--0	----	----	----	----	--0	----	----	----
Net common stock issuance	-23.91%197.91M	144.47%463.28M	-100.00%1K	--203.18M	--0	--260.1M	-6.72%189.5M	--189.5M	--0	--0
Proceeds from stock option exercised by employees	--364K	-24.99%2.47M	6.90%1.15M	--0	127.84%1.33M	--0	-90.61%3.3M	-74.14%1.07M	-98.92%225K	-84.32%582K
Net other financing activities	-143.70%-4.7M	-5.51%-2.8M	---186K	---379K	---301K	---1.93M	---2.65M	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	-25.02%193.58M	143.47%462.96M	-99.50%962K	90,033.33%202.8M	149.59%1.03M	18,119.62%258.17M	-20.53%190.15M	4,492.17%190.58M	-98.92%225K	-101.26%-2.07M
Net cash flow
Beginning cash position	-23.87%181.32M	182.47%238.16M	167.76%334.15M	158.89%296.44M	458.61%549.91M	182.47%238.16M	15.73%84.31M	92.96%124.8M	28.88%114.51M	-28.68%98.44M
Current changes in cash	-112.90%-40.21M	-135.17%-54.1M	-237.48%-155.85M	285.80%39.7M	-1,654.74%-249.71M	2,106.16%311.75M	1,242.60%153.85M	477.24%113.37M	142.57%10.29M	132.65%16.06M
Effect of exchange rate changes	---491K	---2.74M	--3.02M	---1.99M	---3.77M	--0	----	----	--0	----
End cash Position	-74.43%140.62M	-23.87%181.32M	-23.87%181.32M	167.76%334.15M	158.89%296.44M	458.61%549.91M	182.47%238.16M	182.47%238.16M	92.96%124.8M	28.88%114.51M
Free cash flow	-19.88%-126.45M	-22.65%-384.11M	-8.43%-87.5M	-34.79%-87.66M	-25.86%-103.47M	-23.74%-105.48M	-17.95%-313.18M	-31.39%-80.69M	3.48%-65.04M	-29.21%-82.21M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall